Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Prior Centanafadine SR 200 mg	156
Overall Study	STARTED	Prior Centanafadine SR 400 mg	151
Overall Study	STARTED	Prior Placebo	187
Overall Study	STARTED	De Novo Centanafadine SR 400 mg	168
Overall Study	Safety Sample	Prior Centanafadine SR 200 mg	154
Overall Study	Safety Sample	Prior Centanafadine SR 400 mg	149
Overall Study	Safety Sample	Prior Placebo	184
Overall Study	Safety Sample	De Novo Centanafadine SR 400 mg	166
Overall Study	COMPLETED	Prior Centanafadine SR 200 mg	78
Overall Study	COMPLETED	Prior Centanafadine SR 400 mg	72
Overall Study	COMPLETED	Prior Placebo	92
Overall Study	COMPLETED	De Novo Centanafadine SR 400 mg	103
Overall Study	NOT COMPLETED	Prior Centanafadine SR 200 mg	78
Overall Study	NOT COMPLETED	Prior Centanafadine SR 400 mg	79
Overall Study	NOT COMPLETED	Prior Placebo	95
Overall Study	NOT COMPLETED	De Novo Centanafadine SR 400 mg	65

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03605849/flow